163 related articles for article (PubMed ID: 18837205)
1. Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia: a case report.
Hamann S; Sloan PA; Witt W
J Opioid Manag; 2008; 4(4):251-4. PubMed ID: 18837205
[TBL] [Abstract][Full Text] [Related]
2. Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: a retrospective review.
Rebel A; Sloan P; Andrykowski M
J Opioid Manag; 2009; 5(6):331-9. PubMed ID: 20073407
[TBL] [Abstract][Full Text] [Related]
3. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients.
Bijur PE; Schechter C; Esses D; Chang AK; Gallagher EJ
J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272
[TBL] [Abstract][Full Text] [Related]
4. A paradoxical, novel approach: combining minute naloxone with morphine intrathecal infusion.
Ruan X
J Opioid Manag; 2008; 4(5):267. PubMed ID: 19070264
[No Abstract] [Full Text] [Related]
5. Ultralow Dose of Naloxone as an Adjuvant to Intrathecal Morphine Infusion Improves Perceived Quality of Sleep but Fails to Alter Persistent Pain: A Randomized, Double-blind, Controlled Study.
Block L; Lundborg C; Bjersing J; Dahm P; Hansson E; Biber B
Clin J Pain; 2015 Nov; 31(11):968-75. PubMed ID: 25629634
[TBL] [Abstract][Full Text] [Related]
6. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
Hamann S; Sloan P
J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal ultra-low dose naloxone enhances the antihyperalgesic effects of morphine and attenuates tumor necrosis factor-α and tumor necrosis factor-α receptor 1 expression in the dorsal horn of rats with partial sciatic nerve transection.
Yang CP; Cherng CH; Wu CT; Huang HY; Tao PL; Lee SO; Wong CS
Anesth Analg; 2013 Dec; 117(6):1493-502. PubMed ID: 24257399
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of high-dose intrathecal morphine for analgesia after pelvic surgery.
Rebel A; Sloan P; Andrykowski M
Pain Res Manag; 2011; 16(1):19-26. PubMed ID: 21369537
[TBL] [Abstract][Full Text] [Related]
12. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period.
Cepeda MS; Africano JM; Manrique AM; Fragoso W; Carr DB
Pain; 2002 Mar; 96(1-2):73-9. PubMed ID: 11932063
[TBL] [Abstract][Full Text] [Related]
13. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Ultra-low-dose Intrathecal Naloxone on Pain Intensity After Lumbar Laminectomy With Spinal Fusion: A Randomized Controlled Trial.
Firouzian A; Gholipour Baradari A; Ehteshami S; Zamani Kiasari A; Shafizad M; Shafiei S; Younesi Rostami F; Alipour A; Ala S; Darvishi-Khezri H; Haddadi K
J Neurosurg Anesthesiol; 2020 Jan; 32(1):70-76. PubMed ID: 30273200
[TBL] [Abstract][Full Text] [Related]
15. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
Ibuki T; Dunbar SA; Yaksh TL
Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain.
Anderson VC; Burchiel KJ
Neurosurgery; 1999 Feb; 44(2):289-300; discussion 300-1. PubMed ID: 9932882
[TBL] [Abstract][Full Text] [Related]
17. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
Duse G; Davià G; White PF
Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
[TBL] [Abstract][Full Text] [Related]
18. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
[TBL] [Abstract][Full Text] [Related]
19. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.
Liu HJ; Gao XZ; Liu XM; Xia M; Li WY; Jin Y
J Palliat Med; 2014 Jul; 17(7):837-40. PubMed ID: 24702571
[TBL] [Abstract][Full Text] [Related]
20. The effect of a low-dose naloxone infusion on the incidence of respiratory depression after intrathecal morphine administration for major open hepatobiliary surgery: a randomised controlled trial.
Cosgrave D; Vencken S; Galligan M; McGuinness S; Soukhin E; McMullan V; Nair S; Puttappa A; Boylan J; Hussain R; Conlon N; Doran P; Nichol A
Anaesthesia; 2020 Jun; 75(6):747-755. PubMed ID: 31792949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
